DOCN: financial statements from SEC

Income statement

Metric	Dec 31, 2025	Dec 31, 2024
Revenue	901m	781m
Cost of revenue	362m	315m
Gross profit	540m	466m
Research and development	162m	142m
Selling, general and administrative	139m	161m
Operating expenses	383m	375m
Operating income	157m	91m
Pre-tax income	207m	98m
Income tax	−53m	13m
Net income	259m	84m
Earnings per share	2.83	0.92
Earnings per share, diluted	2.52	0.89
Weighted average shares	91m	92m
Weighted average shares, diluted	105m	95m

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	741m	254m	237m	388m	360m	428m	440m	443m
Short-term investments	—	—	—	—	—	0	0	0
Receivables	105m	91m	84m	81m	77m	72m	69m	67m
Current assets	944m	427m	368m	510m	479m	542m	552m	544m
Property, plant and equipment	754m	589m	521m	466m	446m	433m	371m	367m
Goodwill	351m	349m	349m	349m	349m	349m	349m	349m
Total assets	2.57bn	1.84bn	1.73bn	1.72bn	1.64bn	1.64bn	1.53bn	1.54bn
Current liabilities	647m	619m	325m	225m	198m	221m	176m	220m
Short-term debt	311m	325m	10m	—	—	0	—	—
Long-term debt	608m	971m	1.28bn	1.49bn	1.49bn	1.49bn	1.48bn	1.48bn
Total liabilities	1.68bn	1.87bn	1.80bn	1.90bn	1.85bn	1.84bn	1.74bn	1.79bn
Equity	887m	−29m	−70m	−175m	−211m	−203m	−212m	−254m
Shares outstanding	104m	92m	91m	91m	91m	92m	92m	92m
Shares issued	104m	92m	91m	91m	91m	92m	92m	92m

Metric	Dec 31, 2025	Dec 31, 2024
Operating cash flow	310m	283m
Depreciation and amortisation	137m	130m
Share-based compensation	80m	91m
Capital expenditure	129m	178m
Investing cash flow	−268m	−95m
Share buybacks	82m	60m
Financing cash flow	−217m	−76m